Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.25 USD | -2.05% | +1.22% | +9.05% |
12:46pm | Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise | MT |
12:04pm | Haemonetics Corporation Provides Revenue Guidance for the Fiscal Year 2025 | CI |
Financials (USD)
Sales 2024 * | 1.3B | Sales 2025 * | 1.37B | Capitalization | 4.74B |
---|---|---|---|---|---|
Net income 2024 * | 126M | Net income 2025 * | 158M | EV / Sales 2024 * | 3.66 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.45 x |
P/E ratio 2024 * |
37.3
x | P/E ratio 2025 * |
28.2
x | Employees | 3,034 |
Yield 2024 * |
2.14% | Yield 2025 * |
2.14% | Free-Float | 99.24% |
Latest transcript on Haemonetics Corporation
1 day | -2.05% | ||
1 week | +1.22% | ||
Current month | +1.41% | ||
1 month | +9.29% | ||
3 months | +19.38% | ||
6 months | +8.22% | ||
Current year | +9.05% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 16-05-15 | |
James D'Arecca
DFI | Director of Finance/CFO | 53 | 22-04-10 |
Jan Hartmann
CTO | Chief Tech/Sci/R&D Officer | - | 06-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Abernathy
BRD | Director/Board Member | 69 | 17-10-17 |
Director/Board Member | 69 | 14-07-22 | |
Ellen Zane
CHM | Chairman | 72 | 18-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.28% | 0 M€ | +2.66% | ||
0.14% | 0 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 93.25 | -2.05% | 911,094 |
24-05-07 | 95.2 | -0.19% | 768,803 |
24-05-06 | 95.38 | +1.04% | 388,144 |
24-05-03 | 94.4 | +1.15% | 368,663 |
24-05-02 | 93.33 | +1.30% | 345,709 |
Delayed Quote Nyse, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.05% | 4.74B | |
-4.66% | 183B | |
-1.01% | 108B | |
-4.20% | 67.51B | |
+2.68% | 50.67B | |
+9.12% | 44.7B | |
+2.41% | 40.95B | |
+3.31% | 26.8B | |
+4.13% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- HAE Stock